2077 studies found for:    Lipid Storage Diseases
Show Display Options
Rank Status Study
21 Completed Omega 3 in Intervention Spinal Cord Injured People
Conditions: Lipid Metabolism Disorders;   Peroxidase; Defect
Interventions: Dietary Supplement: w3 supplement in SCI;   Other: placebo
22 Completed
Has Results
Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Condition: Lipid Metabolism Disorders
Intervention: Drug: Fluvastatin sodium
23 Completed Stearidonic Acid and Lipid Metabolism
Condition: Lipid Metabolism Disorders
Interventions: Dietary Supplement: Echium oil (SDA-rich oil);   Dietary Supplement: high-oleic acid sunflower oil (HOSO) (low in SDA)
24 Completed Study of the Long-term Effects of Exercise on Heath Indicators in Older People
Conditions: Hypertension With Complications and Secondary Hypertension;   Overweight and Obesity;   Lipid Metabolism Disorders;   Sarcopenia;   Osteoporosis;   Personal Satisfaction
Intervention: Behavioral: Exercise training
25 Completed Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
Conditions: Lipid Metabolism Disorders;   Sterols;   Diet, High-Fat;   Cholesterol;   Fatty Acids;   Hyperlipidemias
Interventions: Behavioral: Changes in cholesterol metabolism;   Other: Lean red meat diet;   Other: Fat red meat diet
26 Completed Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
Condition: Lipid Metabolism Disorder
Intervention: Drug: ezetimibe
27 Completed
Has Results
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
28 Completed An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: Mipomersen Sodium
29 Completed
Has Results
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen;   Drug: Placebo
30 Recruiting The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study
Condition: Lipid Metabolism Disorders
Interventions: Dietary Supplement: Artichoke Leaf Extract;   Other: Placebo
31 Completed
Has Results
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
Conditions: Lipid Metabolism, Inborn Errors;   Hyperlipidemias;   Metabolic Diseases;   Hypolipoproteinemia;   Hypolipoproteinemias;   Hypobetalipoproteinemias;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Congenital Abnormalities;   Metabolic Disorder;   Hypercholesterolemia;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen;   Drug: Placebo
32 Completed A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 in Subjects With Hypercholesterolemia
Conditions: Hypercholesterolemia;   Dyslipidemias;   Hyperlipidemias;   Lipid Metabolism Disorders;   Metabolic Diseases
Intervention: Biological: PF-04950615
33 Unknown  Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years
Conditions: Vascular System Injuries;   Lipid Metabolism Disorders;   Endothelial Disfunction
Interventions: Drug: Resveratrol;   Behavioral: Caloric restriction
34 Completed
Has Results
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
Conditions: Metabolic Diseases;   Hyperlipidemias;   Metabolic Disorder;   Hypercholesterolemia;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen;   Drug: placebo
35 Completed Multiple Treatment Study
Condition: Body Fat Disorder
Intervention: Device: The Zeltiq System
36 Completed Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
Conditions: Hyperlipidemias;   Hypertriglyceridemia;   Dyslipidemias;   Lipid Metabolism Disorders;   Metabolic Diseases
Interventions: Drug: CAT-2003;   Drug: Placebo
37 Recruiting Alpha-linolenic Acid and Blood Pressure
Conditions: Hypertension;   Lipid Metabolism Disorders
Interventions: Dietary Supplement: Flaxseed oil;   Dietary Supplement: high oleic sunflower oil (HOSF)
38 Recruiting The Metabolic Effect of Walnuts in Healthy Subjects
Condition: Lipid Metabolism Disorders
Intervention: Other: walnuts
39 Active, not recruiting Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Conditions: Mucopolysaccharidosis;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy (ALD);   Krabbe Disease;   Metachromatic Leukodystrophy (MLD);   Sphingolipidoses;   Peroxisomal Disorders
Interventions: Drug: Campath-1H;   Drug: Cyclophosphamide;   Drug: Busulfan;   Procedure: Allogeneic stem cell transplantation;   Drug: Cyclosporine A;   Drug: Mycophenolate Mofetil
40 Recruiting Causes and Natural History of Dyslipidemias
Condition: Dyslipidemias
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years